Pharmafile Logo

OPEN Health’s response to the FDA’s guidance on long term follow up post gene therapy

January 29, 2020 |  

Written by Gavin Jones, OPEN Health

The FDA has published their industry guidance on the topic of long term follow up (LTFU) post gene therapy. Please see a link to the full guidance below. In summary, they are stipulating that a good proportion of these therapies will require LTFU of up to fifteen years.

This presents significant challenge to manufacturers given that patients will, in that stretch of time, have multiple changes to their care settings and life circumstances. In addition to this, and if these therapies live up to their promise, treated ‘patients’ will potentially become chronically well and keen to disengage from their previous disease state and their healthcare professionals.

This is a significant challenge but achievable! We have already shared our experienced thinking on this topic and a link to our article is provided below. Our recommendations focus on putting the patient at the centre of a solution and wrapping a, digitally enabled, registry solution around thoughtful patient and healthcare professional engagement.

Please read our full thinking below:

http://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pubname=&edid=5cf08b2f-f3d9-435a-8255-ef07542eb9a3&pnum=31

https://www.fda.gov/media/113768/download

Pink divider

Get in touch

If you would like to discuss further please contact our director of rare disease: gavinjones@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health's latest partnership with Rare Revolution Magazine

Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)

OPEN Health CSR Report 2019

Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.

OPEN Health at ECRD 2020

Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.

OPEN Health discuss Global Community in Rare Disease

Annie Rankin how we can work smarter with healthcare professionals

OPEN Health Patient & Brand Communications highly commended finalist

Shortlisted for Best Patient-Centric Approach for 2020 BOBI Awards.

Succeeding with Star Wars Medicine

OPEN Health have published a new white paper demonstrating their commitment to leading the conversation on how effective healthcare communications, and tools that enable them, can lead to faster and...

Three steps I take for stress-free, successful virtual meetings and events

Stacey Osafo, Senior Account Manager, talks about some practical steps she uses for successful virtual meetings and events based on OPEN Health’s vast experience

OPEN Conversations - a webinar series with OPEN Health

OPEN Conversations is a webinar series where experts from OPEN Health answer your questions on pertinent topics in healthcare communications. Available live and on-demand, you can now catch up on...

COVID-19 message to clients from OPEN Health CEO, David Rowley

Dear OPEN Health Clients,I want to highlight to our clients what we’re doing in response to the Coronavirus outbreak to protect our staff, our clients and the community.We’re following the...

The field team are off the road! What should they do next?

Written by Briony Frost , OPEN Health